Syneos Health, Inc. Class A Common Stock
SYNH
SYNH was delisted on the 27th of September, 2023.
305 hedge funds and large institutions have $3.73B invested in Syneos Health, Inc. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 118 increasing their positions, 104 reducing their positions, and 76 closing their positions.
147% more call options, than puts
Call options by funds: $6.87M | Put options by funds: $2.78M
13% more repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 104
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 336 → 305 (-31)
19% less capital invested
Capital invested by funds: $4.58B → $3.73B (-$854M)
34% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 76
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$125M |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$82.1M |
| 3 |
D.E. Shaw & Co
New York
|
+$72.1M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$51M |
| 5 |
Morgan Stanley
New York
|
+$40.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$97.8M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$54.9M |
| 3 |
CCMLC
Cardinal Capital Management LLC (Connecticut)
Greenwich,
Connecticut
|
-$46.2M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$45.4M |
| 5 |
CB
Cooke & Bieler
Philadelphia,
Pennsylvania
|
-$39.8M |
SYNH Hedge Fund Activity: Q4 2022 in Review
305 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q4 2022, worth a combined $3.73B — down 19% from $4.58B a quarter earlier.
Sellers outnumbered buyers: 76 funds closed out of SYNH and 50 opened new positions — a net loss of 26 holders — while 104 trimmed existing stakes and 118 added.
The largest buyer was Goldman Sachs, adding an estimated $125M. The largest seller was Fidelity Investments, cutting an estimated $97.8M.
- 305 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q4 2022, down from 336 in Q3 2022.
- Funds reported $3.73B of Syneos Health, Inc. Class A Common Stock stock for Q4 2022, down 19% quarter-over-quarter.
- 50 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q4 2022 and 76 closed out, a net change of -26 holders.
- The largest Syneos Health, Inc. Class A Common Stock buyer in Q4 2022 was Goldman Sachs, an estimated $125M added.
- The largest Syneos Health, Inc. Class A Common Stock seller in Q4 2022 was Fidelity Investments, an estimated $97.8M sold.
Based on aggregated 13F filings for Q4 2022.